Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of agomelatine on CLOCK gene expression in major depressive disorder and healthy controls
2010-021044-17Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of agomelatine in major depressive disorder (MDD) and Seasonal Affective Disorder (SAD) (2 arms), sponsored by Medical University of Vienna. Started Aug 2010; status: terminated.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)Seasonal Affective Disorder (SAD)
Beyond the preview
Go deeper on 2010-021044-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021044-17.